| Trial-Results center | |||
| Clinical trial results database |
 Feedback
 Home
|
This trial is included in the following systematic reviews and meta-analyses:
acute coronary syndrome
-
antithrombotics
-
unstable angina
acute coronary syndrome
-
antithrombotics
-
all type of patient
acute coronary syndrome
-
heparin (UFH or LMWH)
-
all type of patients
Related trials
J-LANCELOT, 2010 - atopaxar vs placebo
CURRENT - OASIS 7 (ASA), 2010 - ASA high dose vs ASA low dose
CURRENT OASIS 7 (clopidogrel), 2010 - clopidogrel double-dose vs clopidogrel standard-dose
PLATO, 2009 - ticagrelor + aspirin vs clopidogrel + aspirin
ATLAS ACS-TIMI 46, 2009 - rivaroxaban vs placebo
APPRAISE-1 (2.5 mg bid), 2009 - apixaban vs placebo
APPRAISE-1 (10mg od), 2009 - apixaban vs placebo
SEPIA-ACS1 TIMI 42, 2009 - otamixaban vs unfractioned heparin
DISPERSE-2 (90mg), 2007 - ticagrelor + aspirin vs clopidogrel + aspirin
OASIS 5, 2006 - fondaparinux vs enoxaparin
PROTECT-TIMI 30, 2006 - Bivalirudin vs eptifibatide + heparin
INTERACT, 2006 - enoxaparin vs UFH (on top of aspirin)
SYNERGY, 2005 - enoxaparin vs UFH (on top of aspirin)
EVET, 2005 - enoxaparin vs tinzaparin
LoWASA, 2004 - warfarin vs control (on top of aspirin)
PENTUA, 2004 - fondaparinux vs enoxaparin
Zibaeenezhad, 2004 - warfarin vs control (on top of aspirin)
ASPECT-2 (coumadin+asp vs asp), 2002 - coumadin vs control (on top of aspirin)
WARIS, 2002 - warfarin vs control (on top of aspirin)
ASPECT-2 (coumadin vs aspirin), 2002 - coumadin vs aspirin
CHAMP, 2002 - warfarin vs control (on top of aspirin)
APRICOT-2, 2002 - warfarin vs control (on top of aspirin)
OASIS-2 Warfarin Substudy, 2001 - warfarin vs control (on top of aspirin)
See also:
RESCUE study, |
|
| [NCT00077818] | |
Treatments
| Studied treatment |
Enoxaparin
|
| Control treatment |
unfractionated heparin
|
Patients
| Patients | patients diagnosed with acute coronary syndrome in the emergency department |
Method and design
| Randomized effectives | NA / NA (studied vs. control) |
| Design | Parallel groups |
| Blinding | open |
| Follow-up duration | 30 days |
| Primary endpoint | death, MI, recurrent angina requiring revasc |
Results
No results available for this trial - no clinical endpoint reported
Reference(s)
| Trials register # | NCT00077818 |
(c) 2004-2010 TrialResults-center - All Rights Reserved
Tweet this
notify a friend